Abeona Therapeutics Inc.
ABEONASDAQHealthcare● Active
$5.38
$-0.08(-1.47%)
Market Cap$306633875
P/E Ratio—
52W High$7.54
52W Low$4
Abeona Therapeutics Inc. (ABEO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ABEO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $5.82M | $0.00M | $3.50M | $1.41M | $3.00M |
| Cost of Revenue | $1.53M | $2.91M | $1.60M | $0.45M | $0.00M |
| Gross Profit | $4.29M | ($2.91M) | $1.90M | $0.96M | $3.00M |
| Gross Margin %(computed) | 73.68% | — | 54.14% | 68.18% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $26.81M | $34.36M | $31.09M | $28.96M | $38.73M |
| G&A Expenses | $65.03M | $29.85M | $19.00M | $17.26M | $21.64M |
| Total Operating Expenses | $93.74M | $61.30M | $49.03M | $51.88M | $92.84M |
| Operating Income | ($89.45M) | ($64.21M) | ($47.13M) | ($50.91M) | ($89.84M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $5.56M | $4.25M | $2.12M | $0.43M | $0.04M |
| Interest Expense | $3.74M | $4.21M | $0.42M | $0.74M | $3.66M |
| Income Before Tax | $71.28M | ($63.73M) | ($54.19M) | ($39.70M) | ($84.94M) |
| Income Tax Expense | $0.10M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | $71.18M | ($63.73M) | ($54.19M) | ($39.70M) | ($84.94M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.34 | $-1.55 | $-2.53 | $-5.53 | $-21.50 |
| Wtd Avg Shares | 52.95M | 41.05M | 21.38M | 7.86M | 3.94M |
| EBITDA | ($85.89M) | ($56.62M) | ($50.57M) | ($34.38M) | ($76.82M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Abeona Therapeutics Inc. data
About Abeona Therapeutics Inc. (ABEO) Income Statement
Abeona Therapeutics Inc. (ABEO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ABEO reported revenue of $0.01B, gross profit of $0.00B (gross margin 73.68%), and net income of $0.07B — a net profit margin of 1223.08%.
Frequently asked questions
ABEO · 4 questionsAbeona Therapeutics Inc. (ABEO) reported revenue of $0.01B for 2025, up —% year-over-year.
ABEO revenueABEO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08